Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Mar;430(3):247-51.
doi: 10.1007/BF01324809.

Comparative analysis of clonality and pathology in primary and secondary hyperparathyroidism

Affiliations

Comparative analysis of clonality and pathology in primary and secondary hyperparathyroidism

L Shan et al. Virchows Arch. 1997 Mar.

Abstract

Parathyroid adenoma and hyperplasia are the most common causes for hyperparathyroidism, and distinction between them is controversial based on the current criteria for pathological diagnosis. We studied the clonality of hyperparathyroidism and its correlation with the pathological features, analysing 39 female patients with hyperparathyroidism. Clonality was successfully detected in 12 heterozygous cases by PCR amplification of PGK-1 gene. The 12 cases yielded 14 hypercellular glands, 8 affected by primary and 6 by secondary hyperparathyroidism. The results revealed that 7 of the 8 glands with primary hyperparathyroidism showed monoclonal proliferation. Only 1 gland pathologically diagnosed as adenoma showed a polyclonal pattern. In the 4 cases with secondary hyperparathyroidism, at least one monoclonal tumour was detected in each case. Our data indicate that monoclonal tumours are more common than expected in both primary and secondary hyperparathyroidism. Monoclonal tumours and polyclonal hyperplasia can co-exist in the same patient. Comparative study of the clonality and the pathological features showed that the clonality was consistent with the diagnosis of parathyroid adenoma, whereas it was in conflict with the diagnosis of hyperplasia with multigland involvement. One of the reasons for this is that we are ignorant of the true natures of hyperparathyroidism with multigland involvement.

PubMed Disclaimer

References

    1. J Clin Endocrinol Metab. 1993 Jan;76(1):139-44 - PubMed
    1. Cancer Res. 1993 Oct 1;53(19):4676-9 - PubMed
    1. N Engl J Med. 1989 Jul 27;321(4):213-8 - PubMed
    1. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6848-52 - PubMed
    1. Biochem Biophys Res Commun. 1985 Jul 16;130(1):118-26 - PubMed

Publication types

Substances

LinkOut - more resources